Repeat venous sinus stenting for management of recurrent sinus stenosis related treatment failure of idiopathic intracranial hypertension: A case series
- PMID: 40468762
- PMCID: PMC12141266
- DOI: 10.1177/15910199251332396
Repeat venous sinus stenting for management of recurrent sinus stenosis related treatment failure of idiopathic intracranial hypertension: A case series
Abstract
BackgroundDural venous sinus stenting (VSS) has been shown to be an effective treatment for idiopathic intracranial hypertension (IIH); however over time, some patients develop treatment failure with formation of a juxta-stent stenosis and a new pressure gradient. Repeat stenting can be performed in these patients to alleviate the stenosis and relieve the elevated pressures preventing complications such as blindness. The efficacy and long-term outcomes of re-stenting is not well described in the literature.MethodsA retrospective review of patients treated at our institution for IIH with VSS over a span of 18 years identified 18 patients who underwent re-stenting for treatment failure. Clinical features, outcomes and venographic data were collated for each patient with a follow-up period ranging from 12 months up to 9 years from their second stent.ResultsThe mean time to repeat stenting was 4 years and 12 months with a range of 1 month up to 16 years and 9 months. Four patients (22.2%) were asymptomatic following second stenting and three patients had recurrent papilledema. Two of these patients (11.1%) had surgical shunting and 1 patient (5.56%) received a third stent. 13 patients (72.2%) had ongoing headaches. There were no major complications in any patient.ConclusionsThis case series demonstrates favourable outcomes for repeat VSS in patients who develop juxta-stent stenosis with a pressure gradient after initial stenting for IIH. A proportion of patients have persistent headache likely due to other mechanisms and a minority may require surgical shunting or further stenting.
Keywords: Idiopathic intracranial hypertension; repeat stenting; treatment failure; venous sinus stenting.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Wang MTM, Bhatti MT, Danesh-Meyer HV. Idiopathic intracranial hypertension: pathophysiology, diagnosis and management. J Clin Neurosci 2022; 95: 172–179. - PubMed
-
- Fargen KM, Coffman S, Torosian T, et al. “Idiopathic” intracranial hypertension: an update from neurointerventional research for clinicians. Cephalalgia 2023; 43: 3331024231161323. - PubMed
-
- Fargen KM, Garner RM, Kittel C, et al. A descriptive study of venous sinus pressures and gradients in patients with idiopathic intracranial hypertension. J Neurointerv Surg 2020; 12: 320–325. - PubMed
-
- Kole MJ, Martinez-Gutierrez JC, Sanchez F, et al. Dural venous sinus stenting in patients with idiopathic intracranial hypertension: report of outcomes from a single-center prospective database and literature review. Expert Rev Ophthalmol 2022; 17: 321–331.
-
- Fargen KM. A unifying theory explaining venous sinus stenosis and recurrent stenosis following venous sinus stenting in patients with idiopathic intracranial hypertension. J Neurointerv Surg 2021; 13: 587–592. - PubMed
LinkOut - more resources
Full Text Sources
